http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11202931

Outgoing Links

Predicate Object
contentType Clinical Trial|Clinical Trial, Phase I|Journal Article|Multicenter Study
endingPage 452
issn 0167-6997
1573-0646
issueIdentifier 4
pageRange 445-452
publicationName Investigational New Drugs
startingPage 445
bibliographicCitation Wieder R, Novick SC, Hollis BW, Bryan M, Chanel SM, Owusu K, Camastra D, Saunders T, Pliner L, Harrison J, Bonate P, Williams T, Soignet S. Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies. Invest New Drugs. 2003 Nov;21(4):445–52. doi: 10.1023/a:1026203418976. PMID: 14586212.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a90e3bbe83082c70295a766a33a1f629
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72e24f7c695b47be8a052ec99af8d26a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce24ba8f9ce74e7424b5c0cc31306c28
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb88af7175d5572be8abdaf344f8765b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2dcc606644149e7f99b2a4f2926a146e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a908484ae35704415200581b6eebfd4e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74f956edba76b4ef975abbc1f47ee9e6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d06fa2fd4b2581b17740bbb5cd6eae1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4889eebdfaa98a18dce27ec9132e53d5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09466655e2bfc8a014167d77a362f0e0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_916b71aaf0c079445dbe30e5e3c8d772
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed5a0da6809d058e0567f113c7d20163
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1db5433964b7fd2d23037829c727f6e7
date 200311
identifier https://pubmed.ncbi.nlm.nih.gov/14586212
https://doi.org/10.1023/a:1026203418976
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4372
https://portal.issn.org/resource/ISSN/1573-0646
https://portal.issn.org/resource/ISSN/0167-6997
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies
discusses http://id.nlm.nih.gov/mesh/M0390449
http://id.nlm.nih.gov/mesh/M0004229
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283740
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8063
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6438384
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID101099404
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13019066
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7333
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9953732
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5371993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6437079
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127975875
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129094362

Total number of triples: 54.